Who owns VYNE THERAPEUTICS INC?
- Ticker: VYNE
- CUSIP Number: 92941v308
Tip: Access positions for across all investors
Analyze quarterly positions in Vyne Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vyne Therapeutics stock
Who bought or sold VYNE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cormorant Asset Management | 1.4M | $4.3M | 0% | Mar 2024 |
|
| Eventide Asset Management | 1.4M | $3.1M | 0% | Mar 2024 |
|
| Citadel Advisors | 1.2M | $3.6M | 0% | Mar 2024 |
|
| Parkman Healthcare Partners | 697k | $2.1M | 100% | Mar 2024 |
|
| DSC Advisors | 697k | $2.1M | 0% | Mar 2024 |
|
| Palo Alto Investors | 445k | $1.4M | 0% | Mar 2024 |
|
| AlphaCentric Advisors | 445k | $1.4M | 100% | Mar 2024 |
|
| Exome Asset Management | 415k | $1.3M | 252% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 220k | $675k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 175k | $475k | 13763% | Mar 2024 |
|
| ADAR1 Capital Management | 110k | $338k | 100% | Mar 2024 |
|
| Geode Capital Management | 107k | $328k | 288% | Mar 2024 |
|
| Springbok Capital Management | 95k | $290k | 100% | Mar 2024 |
|
| Vanguard Group | 70k | $214k | 40% | Mar 2024 |
|
| Susquehanna International | 60k | $185k | -20% | Mar 2024 |
|
| BlackRock | 45k | $137k | -1% | Mar 2024 |
|
| Northern Trust | 37k | $114k | 100% | Mar 2024 |
|
| Virtu Financial | 16k | $50k | 100% | Mar 2024 |
|
| Millennium Management | 11k | $34k | -36% | Mar 2024 |
|
| Bank of America Corporation | 2.2k | $6.7k | -21% | Mar 2024 |
|
| Morgan Stanley | 1.9k | $5.7k | -14% | Mar 2024 |
|
| Tower Research Capital | 1.2k | $3.8k | 361% | Mar 2024 |
|
| Russell Investments | 187.00 | $573.996500 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 174.00 | $534.771600 | 1% | Mar 2024 |
|
| Jpmorgan Chase & Co | 169.00 | $528.125000 | 16% | Mar 2024 |
|
| UBS Group | 16.00 | $48.000000 | -98% | Mar 2024 |
|
Who sold out of Vyne Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Soleus Capital Management | Dec 2023 | 704k | $1.6M |
| Fred Alger Management | Dec 2023 | 60k | $140k |
| Hrt Financial | Dec 2023 | 10k | $23k |
| Us Bancorp | Dec 2023 | 4.4k | $10k |
| Federated Investors | Sep 2023 | 127.00 | $513.003800 |
| Steward Partners Investment Advisory | Dec 2023 | 22.00 | $51.000400 |